Cluster Headache Market Expected to Reach $522.98 Million by 2031 | Fresenius SE & Co. KGaA GlaxoSmithKline plc, Novartis AG, Pfizer Inc

Increase in prevalence of patients suffering from cluster headache, and rise in investments for development of novel medications for cluster headache drives the growth of the market. According to the report, the global cluster headache industry generated $356.00 million in 2021, and is estimated to reach $522.98 million by 2031, witnessing a CAGR of 3.9% from 2022 to 2031.

Key Takeaways:

The episodic segment to rule the roost

Triptans segment showcased the fastest CAGR of 4.4% throughout the forecast period.

The online providers segment would register the fastest CAGR of 5.1% during the forecast period.

Asia-Pacific would showcase the fastest CAGR of 4.8% from 2022 to 2031 owing to increase in number of headache disorders.

Sample of the Report- https://www.alliedmarketresearch.com/request-sample/14812

Leading Market Players-

Arrotex Australia Group
AstraZeneca
Dr. Reddy's Laboratories Ltd.
Eli Lilly and Company
Fresenius SE & Co. KGaA
GlaxoSmithKline plc
Novartis AG
Pfizer Inc
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd

Market Segmentation:

Type of Cluster Headache:

Episodic Cluster Headaches: These are cluster headaches that occur in distinct episodes with periods of remission in between.
Chronic Cluster Headaches: Refers to cluster headaches that persist without significant remission periods.

Treatment Type:

Acute/Abortive Treatment: Medications and therapies used to alleviate the pain and symptoms during a cluster headache attack.
Preventive/Prophylactic Treatment: Medications taken regularly to reduce the frequency and severity of cluster headache episodes.

Medication Class:

Triptans: A class of medications commonly used as abortive treatment for cluster headaches.
Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies: Emerging treatments that target CGRP, a molecule implicated in migraine and cluster headaches.
Oxygen Therapy: A non-pharmacological approach involving the inhalation of high-flow oxygen to relieve cluster headache pain.
Steroids: Sometimes used as a short-term treatment to break a cluster headache cycle.
Lithium: An example of a preventive medication used for chronic cluster headache management.

Patient Demographics:

Age: Segmenting the market based on the age of patients, as cluster headaches can affect individuals of various age groups.
Gender: Analyzing differences in treatment approaches and effectiveness between male and female patients.

Geographic Region:

North America: Includes the United States and Canada, where cluster headache prevalence and treatment options may differ.
Europe: Encompasses countries in the European Union and other European regions.
Asia-Pacific: Includes countries like Japan, India, and Australia, which may have varying access to cluster headache treatments.
Middle East and Africa: Encompasses the Middle Eastern and African regions with potentially different healthcare infrastructures and treatment availability.

Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/14812

North America garnered the major share in 2021-

By region, North America held the major share in 2021, garnering more thantwo fifth of the global cluster headache market revenue owing to rise in prevalence of cluster headache cases and increase in number of key players offering novel therapeutics. However, Asia-Pacific would showcase the fastest CAGR of 4.8% from 2022 to 2031 owing to increase in number of headache disorders, rise in awareness campaign, and surge in investments for development of effective drugs for treating cluster headache.

Key findings of the study

By type, the episodic segment was highest contributor to the cluster headache industry in 2021.
On the basis of drug class, the calcium channel blockers segment dominated the market in terms of revenue in 2021. However, the others segment is anticipated to grow at the highest CAGR during the forecast period.
On the basis of distribution channel, the drug stores and retail pharmacies segment dominated the market in terms of revenue in 2021. However, the online providers segment is anticipated to grow at the highest CAGR during the forecast period.
Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/14812

Key Questions Answered in the Intelligent Study

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?

Similar Research Reports for Information, Communication and Technology:

Ambulatory X-Ray Devices Market https://www.alliedmarketresearch.com/ambulatory-x-ray-devices-market-A13405

Brachytherapy Market https://www.alliedmarketresearch.com/brachytherapy-market-A11122

Digital Sphygmomanometer Market https://www.alliedmarketresearch.com/digital-sphygmomanometer-market-A13403

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.